Founders
KS
An evolutionary biologist and founder building at the intersection of biodiversity, deep science, and drug discovery. Based at IISc, Bengaluru, his research group studies animal venoms and develops innovative treatments for snakebite, including monoclonal antibodies and small-molecule therapeutics. Through Venomics AI, he is creating a scalable biodiscovery platform that transforms nature’s toxins into tomorrow’s medicines.
VP
An AI expert and technology leader building at the intersection of computation and drug discovery. He leads the development of advanced machine learning platforms that analyse complex biological data, enabling the identification and optimisation of novel therapeutic candidates. As co-founder of Venomics.AI, he drives the company’s computational strategy, transforming large-scale venom datasets into actionable insights for next-generation medicines.
Scientific & Engineering Team
We are actively expanding our scientific and engineering core. If you are passionate about venom-derived drug discovery and have expertise in any of the following areas, we are looking to hire.
Seeking experts in field ecology and herpetology to lead ethical pan-India expeditions, species identification, and venom sampling.
Looking for experts to design and conduct electrophysiological assays to screen and validate ion channel-targeting venom peptides.
Seeking talent to lead high-throughput venom fractionation, mass spectrometry, and complex peptide sequencing pipelines.
Looking for researchers to map venom gland transcriptomes and profile toxin gene expression across unexplored species.
Seeking experts to assemble and analyze complex genomes, decoding the evolutionary genetics of venomous species.
Seeking engineers to build and scale our deep learning models for target prediction, molecular prioritization, and design.